Kim Kelderman - 31 Jul 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
31 Jul 2024
Net transactions value
-$249,194
Form type
4
Filing time
02 Aug 2024, 16:17:04 UTC
Previous filing
05 Feb 2024
Next filing
19 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $527,800 +14,000 +40% $37.70 49,421 31 Jul 2024 Direct
transaction TECH Common Stock Tax liability $776,994 -9,479 -19% $81.97 39,942 31 Jul 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Option (Right to Buy) Options Exercise $0 -14,000 -51% $0.000000 13,392 31 Jul 2024 Common Stock 14,000 $37.70 Direct F1
holding TECH Stock Option (Right to Buy) 84,308 31 Jul 2024 Common Stock 84,308 $44.33 Direct F1
holding TECH Stock Option (Right to Buy) 109,536 31 Jul 2024 Common Stock 109,536 $47.60 Direct F1
holding TECH Stock Option (Right to Buy) 69,264 31 Jul 2024 Common Stock 69,264 $66.97 Direct F1
holding TECH Stock Option (Right to Buy) 47,952 31 Jul 2024 Common Stock 47,952 $66.97 Direct F2
holding TECH Stock Option (Right to Buy) 25,944 31 Jul 2024 Common Stock 25,944 $120.46 Direct F3
holding TECH Restricted Stock Units 6,984 31 Jul 2024 Common Stock 6,984 Direct F4, F5
holding TECH Performance Stock Option 21,704 31 Jul 2024 Common Stock 21,704 $94.52 Direct F5
holding TECH Stock Options (Right to Buy) 28,940 31 Jul 2024 Common Stock 28,940 $94.52 Direct F6
holding TECH Restricted Stock Units 8,873 31 Jul 2024 Common Stock 8,873 Direct F4, F7
holding TECH Performance Stock Option 23,881 31 Jul 2024 Common Stock 23,881 $84.61 Direct F7
holding TECH Stock Options (Right to Buy) 29,391 31 Jul 2024 Common Stock 29,391 $84.61 Direct F8
holding TECH Stock Options (Right to Buy) 38,252 31 Jul 2024 Common Stock 38,252 $52.83 Direct F9
holding TECH Restricted Stock Units 9,423 31 Jul 2024 Common Stock 9,423 Direct F4, F7
holding TECH Performance Stock Options (Right to Buy) 25,945 31 Jul 2024 Common Stock 25,945 $68.54 Direct F7
holding TECH Stock Options (Right to Buy) 51,890 31 Jul 2024 Common Stock 51,890 $68.54 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Options to purchase 11,988 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F3 Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F5 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
F7 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
F9 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
F10 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.